EuroBiotech: More Articles of Note

newspapers
(Pixabay)

> Zealand Pharma began its relocation to a new headquarters. The new site has lab space. Release 

> A journal published phase 2a data on Santhera Pharmaceuticals’ Duchenne muscular dystrophy drug vamorolone. Statement (PDF)

> The Financial Times reported that the U.K. taxman is targeting GlaxoSmithKline contractors. FT

Sponsored by BHE

[Webinar] State of Data Analytics and Machine Learning in the Life Sciences Industry: 2020 Benchmarking Survey

Thursday, June 25, 2020 | 2:00pm ET | 11:00am PT

Join us Thursday, June 25th for a look at the current state of analytics in the life sciences industry. We will present the results from our industry survey with FiercePharma on how 100 of your peers are leveraging data analytics to respond to today’s challenges and generate timely, high value insights.

> ADC Therapeutics struck a deal to access Freenome’s liquid biopsy platform. Release  

> Boehringer Ingelheim made changes to its leadership team. Statement 

Suggested Articles

Genor Biopharma banked $160 million from the likes of Hillhouse and Temasek Holdings to advance its clinical-stage autoimmune and cancer programs.

Going from being the CSO of Bristol Myers Squibb to running one of the biggest cancer research organizations in the world is a major career shift.

Hahn made the commitment in a speech that called on the FDA to learn from the crisis to enact lasting policies that accelerate drug development.